CD8A and neoplasm: To further validate the crucial role of CD8+ T cells in the anti-tumor effect of the asparagine-targeting and anti-PD-L1 combination therapy, CD8+ T cells and CD4+ T cells were specifically depleted in vivo using anti-mouse CD8 and anti-mouse CD4, respectively.